MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, RNXT had $5,338K increase in cash & cash equivalents over the period. -$3,709K in free cash flow.

Cash Flow Overview

Change in Cash
$5,338K
Free Cash flow
-$3,709K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from common stock and p...
    • Accounts payable
    • Change in fair value of common w...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Issuance cost of common stock up...
    • Accrued expenses
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Noncash lease expense
--23 42
Net loss
-3,521 -2,941 -2,912 -5,315
Stock-based compensation expense
317 285 349 633
Non-cash lease expense
23 88 --
Change in fair value of common warrants classified as a liability
97 -506 -175 -234
Depreciation expenses
1 1 -1 2
Accounts receivable
141 -30 -194 320
Inventory
190 -83 272 -
Prepaid expenses
177 -112 -80 102
Other current assets
-19 158 -143 -15
Deferred offering costs
---0
Accounts payable
254 -70 198 85
Accrued expenses
-391 121 103 -489
Net cash used in operating activities
-3,709 -3,020 -2,270 -5,683
Purchase of property and equipment
0 0 0 2
Net cash used in investing activities
0 0 0 -2
Gross proceeds from equity financing
--12,102 -
Proceeds from common stock and pre-funded common stock warrants
10,000 12,102 --
Issuance cost of common stock upon private placement
953 0 1,299 -
Proceeds from exercise of common stock warrants
-0 0 25
Proceeds from exercise of stock options
0 0 0 17
Proceeds from equity financing, net of issuance cost
---10,803
Net cash provided by financing activities
9,047 0 0 10,845
Net increase in cash and cash equivalents
5,338 -3,020 -2,270 5,160
Beginning of period
7,024 -2,890 7,154 -
End of period
12,362 -3,020 10,044 -
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from commonstock and pre-funded...$10,000K Net cash provided byfinancing activities$9,047K Canceled cashflow$953K Net increase in cashand cash...$5,338K Canceled cashflow$3,709K Issuance cost of commonstock upon private...$953K Stock-based compensationexpense$317K Accounts payable$254K Change in fair value ofcommon warrants...$97K Non-cash lease expense$23K Other current assets-$19K Depreciation expenses$1K Net cash used inoperating activities-$3,709K Canceled cashflow$711K Net loss-$3,521K Accrued expenses-$391K Inventory$190K Prepaid expenses$177K Accounts receivable$141K

RenovoRx, Inc. (RNXT)

RenovoRx, Inc. (RNXT)